Group One Trading’s Foundation Medicine, Inc. FMI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-153,300
Closed -$21M 5952
2018
Q2
$21M Buy
153,300
+50,900
+50% +$4.62M 0.18% 89
2018
Q1
$8.06M Buy
102,400
+24,800
+32% +$1.83M 0.08% 290
2017
Q4
$5.29M Sell
77,600
-27,100
-26% -$1.41M 0.04% 610
2017
Q3
$4.21M Buy
104,700
+6,300
+6% +$243K 0.04% 599
2017
Q2
$3.91M Buy
98,400
+79,500
+421% +$2.91M 0.04% 573
2017
Q1
$610K Sell
18,900
-44,700
-70% -$1.12M 0.01% 1709
2016
Q4
$1.13M Buy
63,600
+33,000
+108% +$711K 0.01% 1244
2016
Q3
$715K Sell
30,600
-56,900
-65% -$1.29M 0.01% 1534
2016
Q2
$1.63M Buy
87,500
+11,400
+15% +$206K 0.02% 929
2016
Q1
$1.38M Buy
76,100
+8,200
+12% +$132K 0.02% 966
2015
Q4
$1.43M Buy
67,900
+37,500
+123% +$723K 0.02% 1074
2015
Q3
$561K Buy
30,400
+27,200
+850% +$679K 0.01% 1685
2015
Q2
$108K Sell
3,200
-33,200
-91% -$1.34M ﹤0.01% 3030
2015
Q1
$1.75M Buy
36,400
+35,700
+5,100% +$1.62M 0.03% 715
2014
Q4
$16K Buy
700
+600
+600% +$13.8K ﹤0.01% 4061
2014
Q3
$2K Buy
+100
New +$2.38K ﹤0.01% 4966
2014
Q2
Sell
-4,100
Closed -$133K 5693
2014
Q1
$133K Buy
+4,100
New +$133K ﹤0.01% 2802

Group One Trading's FMI Position: Q3 2017 in Review

Group One Trading sold out of Foundation Medicine, Inc. (FMI) in Q3 2017, closing a stake of 42,629 shares — an estimated $1.64M sold.

Group One Trading first reported a position in FMI in Q1 2014 and held it in 13 quarters. The position peaked at $9.56M in Q1 2017. 97 funds tracked by Wall St. Rank hold FMI as of Q3 2017.

  • Group One Trading reported no remaining Foundation Medicine, Inc. position as of Q3 2017 after selling out during the quarter.
  • Group One Trading sold 42,629 Foundation Medicine, Inc. shares in Q3 2017, an estimated $1.64M.
  • Group One Trading first reported a position in Foundation Medicine, Inc. in Q1 2014 and held it in 13 quarters.
  • Group One Trading's Foundation Medicine, Inc. position peaked at $9.56M in Q1 2017.
  • 97 funds tracked by Wall St. Rank held Foundation Medicine, Inc. as of Q3 2017.

Based on Group One Trading's 13F filing for Q3 2017, filed 15 Nov 2017.